본 연구는 닭 진드기 구제를 목적으로 개발된 살비제인 와구잡이 II® (WGJB, 편백정유 : 계피정유 = 20 : 56)에 대하여 토끼와 기니픽을 이용하여 피부 자극성 및 감작성 평가를 각각 수행하였다. 일차피부자극시험에서 토끼의 피부에 WGJB를 24시간 동안 처리한 후 피부 자극성을 확인한 결과, WGJB는 비찰과 부위에서 홍반과 부종과 같은 어떠한 부작용도 일으키지 않았으나, 몇몇 토끼의 찰과 부위에서 매우 약한 홍반과 부종을 나타내어 WGJB의 1차 피부자극 지수는 0.625이었다. 따라서 WGJB는 약한 자극성이 있는 물질로 분류되었다. 피부감작성 시험에서 기니픽에 0.1 mL의 WGJB을 피내주사한 후 24시간 동안 감작시켰다. 감작 1주일 후 WGJB를 함유한 패취를 주사 부위에 부착하여 48시간 동안 처리한 다음, 2주 후에 WGJB 를 함유한 패취를 부착하여 감작을 야기시켰다. WGJB는 어떠한 알러지 반응도 나타내지 않았다. 따라서, 본 연구를 통하여 WGJB는 약한 피부 자극성을 가지며 감작성을 야기하지 않는 물질로 평가되었다.

This study investigated the antibacterial activity against Staphylococcus (S.) aureus, Salmonella (S.) typhimurium and Escherichia (E.) coli O157:H7, and skin irritation in New Zealand white rabbits using methanol extracts of Curcuma (C.) aromatica Salisb. The minimum inhibitory concentration (MIC) of C. aromatica extracts against S. aureus, S. typhimurium and E. coli O157:H7 was 0.250, 0.250 and 0.125 mg/ml, respectively, and the minimum bactericidal concentration (MBC) of the extracts against S. aureus, S. typhimurium and E. coli O157:H7 was 0.50, 0.50, 0.250 mg/ml, correspondingly. From the skin irritation test, extremely minor erythema and very slight edema were formed at 24 h after application of the extracts on the skin on abraded lesions of 2 and 1 rabbits, respectively. The primary irritation index score was estimated to be 0.13 indicating non-irritation. In conclusion, this study suggests that C. aromatica extract has the antibacterial activity against major food-borne pathogens and is not irritant to skin.

Growth factors and cytokines play an important role in delaying skin aging. However, there has been no animal stability test reported for them yet. In the present study, we examined the plausibility of Growth factor and Cytokine Mixtures (GCM) as a cosmetic ingredient by assessing skin irritation and ocular irritation for hypersensitivity using New Zealand white rabbits. Skin safety study was performed to evaluate the potential toxicity of GCM based on the irritation test. For the irritation test, GCM was applied to the rabbit skin, and no adverse reaction, such as erythema and edema, had been observed from the exposed skin sites. In the ocular irritation test, the treatment of GCM did not cause any adverse reaction on rabbit eyes, including cornea, iris, and conjunctiva tissues. From the results, both tests proved that GCM makes no irritable reaction on skin and eye mucous membrane of rabbit. Hence, it may be suggested that GCM can be safely applied as a cosmeceutical ingredient without causing any significant hypersensitivity reaction.

본 연구는 오존화 올리브오일이 독성이 적으면서 다양한 종류의 미생물을 치사시킬 수 있으나 경우투여나 복강투여에도 인체에 해가 없는 것으로 알려져 있다. 그리고 국내에서는 아직 동물에 대한 안정성 실험이 없었다. 그래서 본 연구에서는 오존화 올리브오일을 사용하여 동물의 안구를 통한 안정성 실험을 하였다. 구체적인 연구에서는 rabbit에서 오존화오일(고농도)의 동물 눈 안점막 자극을 평가하기 위해 실시하였고, 시험물질 처치부위를 관찰한 결과, 비세척군 및 세척군 모두에서 안점막 자극이 관찰되지 않았다.

This study was conducted to identify suitable experimental conditions for the Bovine Corneal Opacity and Permeability (BCOP) assay, after which the assay was employed using 11 substances listed in the OECD test guideline (TG) 437. The opacity of the corneas was checked on days 1, 2, 3, 4, and 10 after extraction. The only day 1 showed the opacity of below 7 (limit value), which indicated the corneas have to be used in a day after extraction. The treatment time of test substances was evaluated at 3, 5, 10, 15, 20, and 30 min to determine the opacity, permeability and IVIS values. Suitable IVIS values were observed at 5, 10, and 15 min. Two culture temperature conditions, 25°C and 32°C, had similar IVIS values. The washing method suggested in the OECD TG 437 resulted in the most suitable IVIS value. Based on the established conditions, the BCOP assay was conducted using the 11 substances listed in OECD TG 437, and the sensitivity, specificity and accuracy matched those in the guidelines for all test substances. Taken together, the results of this study indicate that suitable domestic conditions for BCOP assay as an alternative eye irritation method were established. The results presented herein will be useful to future studies of other Korean alternative researches.

To determine whether S-(-)-10,11-dihydroxyfarnesic acid methyl ester (DHFAME) produced by Beauveria bassiana CS1029 potentially causes acute skin irritation as a cosmetic ingredient, a skin toxicity test was conducted as recommended for compliance with Korea Food and Drug Administration regulations. New Zealand White rabbits were treated with 100 mg/dose of DHFAME according to standard guidelines. No significant skin lesions or inflammation was observed in the DHFAME-treated group. Furthermore, DHFAME did not appear to cause skin irritation, as assessed by clinical observation of the rabbits. Thus, when taken together, the present results suggest that DHFAME is a promising potential cosmetic ingredient that does not irritate the skin.

This study was designed to evaluate to acute oral toxicity and skin irritation of Chrysanthemum dye in Sprague-Dawley (SD) rats. SD rats were orally treated with Chrysanthemum dye at a dose of 0, 1 and 2 ml/kg body weight. After oral administration, the rats were observed for 14days. In primary skin irritation test, SD rats were dermally treated with Chrysanthemum dye and observed for 3 days. To ensure the safety of Chrysanthemum dye such as the following were observed and tested. We examined the body weight, the feed intake, the clinical signs, the ophthalmological test, the histopathological test, the mortality and skin irritation. As a result, no significant differences were found in body weight, feed intake and histopathological test between control and Chrysanthemum dye treated group. In the result of skin irritation test, Chrysanthemum dye did not induce erythema and edema after topical application. Primary irritation index was “0” in the test. Therefore, it is suggested that Chrysanthemum dye has no effect on acute toxicity and side effect in SD rats and is non-irritant material based on the score “0” of primary irritation index.

This test was performed to evaluate the acute oral toxicity and skin irritation of Lamia-Kill®, disinfectant,containing 20% benzalkonium chloride and 10% citric acid. In acute oral toxicity, Lamia-Kill® was orally administered at dose levels of 2,000, 1,000, 500, 250 and 0 mg/kg body weight. After single oral administration to both sexes of SD rats, the rats were observed for 14 days. In primary skin irritation test, New Zealand white rabbits were dermally treated with Lamia-Kill® for 24 hr and observed for 3 days. All rats treated with Lamia-Kill® were induced no toxic signs in mortalities, clinical findings, body weights and gross findings. Also, the disinfectant did not induce any adverse reactions such as erythema and edema on intact skin sites for the most part rabbits, but on abraded skin sites, some rabbits showed very slight erythema on 24 hr after topical application. With the results of this study,Lamia-Kill® have no effect on acute toxicity and side effect in SD rats and was classified as a practically non-irritating material based on the score 0.50 of primary irritation index.

Various research on the surface of the skin and the relationship between epidermis and composition of ion have been performed. Traditionally, bamboo extract was used as an important material for enhancing healthy condition of a skin. Bamboo salt is well known as one of the most famous traditional medical treatments. In this study, we investigated the stability of P/S (Polyol-in-Silicone) emulsions containing a fair amount of bamboo salt in the range of 0.5~5.0 wt%. For improving the stability of emulsions, we varied the quantity of fatty alcohol and wax ester in emulsions and the stability was checked using DSC (Differential Scanning Calorimeter). We also studied the efficacy of treating the P/S emulsions containing bamboo salt. From the experiment, the emulsions show the mitigation of stimuli, enhancing the skin hydration and improving the appearance of the skin.

thus, resembles scar tissue. TGF-β1, MMP and TIMP play an essential role in remodeling extracellular matrix during scar formation. This study investigates the pathogenesis of IF with respect to the coordinated expression of factors involved in wound healing. Proliferative activity and expression of TGF-β1, MMP-1 and TIMP-1 were observed using immunohistochemistry in 88 cases of IF and 9 cases of normal oral mucosa(NOM). Proliferative activity and expression of TGF-β1 and TIMP-1 were increased in IF compared to NOM. MMP-1 expression was not significantly increased in IF. We propose that IF is caused by increased expression of TGF-β1 and an imbalance in expression of MMP-1 and TIMP-1.

In this study, we evaluated the potential of 70% ethanol extract from Persicaria nepalensis (PNE) as a cosmetic ingredient by primary skin irritation, ocular irritation, and maximization tests for delayed hypersensitivity in New Zealand white rabbits and Hartley guinea pig. Skin safety study was performed to evaluate the potential toxicity of PNE using the primary irritation test. In the primary irritation test, 50% PNE was applied to the skin, and no adverse reactions such as erythema and edema were observed at the intact skin sites. Therefore, PNE was classified as a practically non-irritating material based on a primary irritation index of "0.0.". In the ocular irritation test, the 50% PNE applied did not show any adverse reactions in the different parts of rabbit eyes, including the cornea, iris, and conjunctiva. Thus, PNE was classified as a practically non-irritating material based on an acute ocular irritation index of "0.0.". Skin sensitization was tested by the Guinea Pig Maximization Test (GPMT) and Freund's Complete Adjuvant (FCA) using an intradermal injection of 10% PNE. Edema and erythema were not observed 24 and 48 h after the topical application of PNE in skin sensitization test, which exhibited a sensitization score of "0.0.". Therefore, it can be suggested that P. nepalensis could be used as potential candidates for cosmoceutical ingredients, without any major side effects.

우리는 평생 동안 하루도 빠짐없이 치약과 같은 구강관리 제품들을 사용한다. 이와 같이 매일 입에 사용되는 제품의 안전성이 담보되어야 함은 매우 중요한 일이다. 이전까지 이루어진 동물시험이나 임상시험에서 치약 내 계면활성제 등에 의한 구강 자극이 유발될 수 있음이 알려져 있다. 하지만, 동물복지를 위하여 유럽 화장품 법안은 화장품과 그에 사용하는 원료에 대한 동물 시험을 금지했다. 그로 인해 여러 분야에서 동물을 대체하거나 동물의 사용을 줄일 수 있는 동물대체 시험법의 개발이 활발하게 이루어지고 있다. 하지만, 현재까지 구강 점막 독성을 측정할 수 있는 방법으로 임상시험과 동물시험이 있었으며, 최근에는 구강 점막 조직 모델이나 구강 세포들을 활용한 방법들이 연구되고 있다. 이번 연구의 목적은 구강관리 제품의 안전성을 확보할 수 있는 동물대체 시험법을 개발하는 것이다. 구강 세포주(YD-38 cell)를 활용해 불용성 물질을 포함한 치약에 대한 시험이 가능하도록 구강 점막 자극 시험법을 개발하였고, 이 시험법으로 이전에 이루어진 동물시험에서 자극유발원으로 알려진 물질에 의한 자극을 구별해낼 수 있었다. 또한, 유아와 어린이 치약의 자극 수준이 일반 성인 치약에 비해 낮음을 증명하였다. 이 결과를 바탕으로 동물을 사용하지 않고 인체에 대한 위해성을 줄일 수 있도록, 구강관리 제품의 구강 점막 자극 수준을 평가할 수 있는 이 시험법이 하나의 새로운 구강 자극 시험 방법으로 사용될 수 있으리라 사료된다.